rdf:type |
|
lifeskim:mentions |
umls-concept:C0019932,
umls-concept:C0020205,
umls-concept:C0205250,
umls-concept:C0205296,
umls-concept:C0205460,
umls-concept:C0220781,
umls-concept:C0220825,
umls-concept:C0243071,
umls-concept:C0439611,
umls-concept:C1707689,
umls-concept:C1883254
|
pubmed:issue |
25
|
pubmed:dateCreated |
2006-12-7
|
pubmed:abstractText |
Replacing the 1alpha-OH group of the natural hormone 1alpha,25-dihydroxyvitamin D(3) (calcitriol) by a 1alpha-CHF(2) group and incorporating a potentiating side chain produced two new hybrid analogs 6 and 7. Both of these two hybrid analogs are as transcriptionally active as calcitriol and are strongly antiproliferative in vitro but are low-calcemic in vivo.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0022-2623
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
14
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
7513-7
|
pubmed:dateRevised |
2007-12-3
|
pubmed:meshHeading |
pubmed-meshheading:17149880-Animals,
pubmed-meshheading:17149880-Antineoplastic Agents,
pubmed-meshheading:17149880-Calcitriol,
pubmed-meshheading:17149880-Calcium,
pubmed-meshheading:17149880-Cell Line,
pubmed-meshheading:17149880-Cell Proliferation,
pubmed-meshheading:17149880-Female,
pubmed-meshheading:17149880-Humans,
pubmed-meshheading:17149880-Keratinocytes,
pubmed-meshheading:17149880-Mice,
pubmed-meshheading:17149880-Radioligand Assay,
pubmed-meshheading:17149880-Rats,
pubmed-meshheading:17149880-Rats, Sprague-Dawley,
pubmed-meshheading:17149880-Receptors, Calcitriol,
pubmed-meshheading:17149880-Stereoisomerism,
pubmed-meshheading:17149880-Structure-Activity Relationship,
pubmed-meshheading:17149880-Transcription, Genetic
|
pubmed:year |
2006
|
pubmed:articleTitle |
Low-calcemic, highly antiproliferative, 1-difluoromethyl hybrid analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation.
|
pubmed:affiliation |
Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|